(Q40307253)
Statements
The effects of ZD1839 (Iressa), a highly selective EGFR tyrosine kinase inhibitor, as a radiosensitiser in bile duct carcinoma cell lines (English)
Kazuaki Chayama
Hideki Miyata
Tamito Sasaki
Kenichi Kuwahara
Masahiro Serikawa